title: A new formulation of flunisolide for intranasal application reduces side effects.
authors.affiliation: Medical Dept. TTA, State University Hospital, Copenhagen, Denmark.
authors.forename: N H
authors.initials: NH
authors.lastname: Nielsen
authors.forename: L
authors.initials: L
authors.lastname: Frølund
authors.forename: C
authors.initials: C
authors.lastname: Bindslev-Jensen
authors.forename: U G
authors.initials: UG
authors.lastname: Svendsen
mesh_terms: D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000368:Aged; D002626:Chemistry, Pharmaceutical; D005260:Female; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D014677:Pharmaceutical Vehicles / Q000009:adverse effects*
chemical_list: D014677:Pharmaceutical Vehicles; D005446:Fluocinolone Acetonide; C007734:flunisolide